CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs

DE LUCA, PAOLA; DALTON, GUILLERMO N; SCALISE, GEORGINA; MOIOLA, CRISTIAN; PORRETTI, JULIANA; MASILLO, CINTIA; KORDON, EDITH; GARDNER, KEVIN; ZALAZAR, FLORENCIA; FLUMIAN, CAROLINA; TODARO, LAURA; VAZQUEZ, ELBA; MEISS, ROBERTO; DE SIERVI, ADRIANA

Oncotarget

Impact Journals

Año: 2016

Metabolic syndrome (MeS) has been identified as a risk factor for breast cancer. C-terminal binding protein 1 (CtBP1) is a co-repressor of tumor suppressor genes that is activated by low NAD+/NADH ratio. High fat diet (HFD) increases intracellular NADH. We investigated the effect of CtBP1 hyperactivation by HFD intake on mouse breast carcinogenesis. We generated a MeS-like disease in female mice by chronically feeding animals with HFD. MeS increased postnatal mammary gland development and generated prominent duct patterns with markedly increased CtBP1 and Cyclin D1 expression. CtBP1 induced breast cancer cells proliferation. Serum from animals with MeS enriched the stem-like/progenitor cell population from breast cancer cells. CtBP1 increased breast tumor growth in MeS mice modulating multiple genes and miRNA expression implicated in cell proliferation, progenitor cells phenotype, epithelial to mesenchymal transition, mammary development and cell communication in the xenografts. These results define a novel function for CtBP1 in breast carcinogenesis